Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Pasqal Reaffirms its Commitment to the EU’s Quantum Ambitions as It Leads Q-PLANET for Neutral-Atom Technologies
GlobeNewswire, Inc.
PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pasqal (NASDAQ: PSQL), a global leader in neutral-atom quantum computing, is coordinating the implementation of Q-PLANET (Quantum Pilot Line for production of Advanced chips for Neutral atom European...
Oak Hill Bio Appoints Joerg Hipp, PhD as Chief Translational Science Officer
GlobeNewswire, Inc.
CAMBRIDGE, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- OHB Pediatrics Ltd d/b/a Oak Hill Bio, a clinical-stage rare disease therapeutics company, today announced the appointment of Joerg Hipp, PhD as Chief Translational Science Officer.
Fund Momentum Opens Its VC and LP Database to AI Agents With a New MCP Server and Pay-Per-Call Access
EIN Presswire
The Vienna venture data company lets Claude, ChatGPT and autonomous agents search 1,100+ VC funds and 650+ LPs, register themselves, and pay per query in USDC. VIENNA, VIENNA, AUSTRIA, October 6, 2026 /EINPresswire.com/ -- Most investor...
Brevo ‘sends the wrong message at the wrong time’ in new ad campaign
GlobeNewswire, Inc.
Austin, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Timing is everything – especially when it’s off. With a major new brand campaign, Brevo, a leader in customer relationship management software, shows what poorly timed marketing can look like.
OtterlyAI Releases Study on German AI Search Citations: 64.9% Linked to German Addresses
GlobeNewswire, Inc.
Persenbeug, LOWER AUSTRIA, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Anyone who wants to be visible in AI answers in Germany is competing mostly against German sources. 64.9% of all citations that AI search engines return on German prompts point to an...
Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion
GlobeNewswire, Inc.
Segment features Kevin Lundquist discussing his decision to join Outlook Therapeutics and the Company’s path forward following the FDA approval of LYTENAVA™ Access the segment here ISELIN, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Outlook...
F2G Announces Abstracts Accepted for Oral and Poster Presentation at IDWeek 2026
GlobeNewswire, Inc.
MANCHESTER, United Kingdom, Oct. 06, 2026 (GLOBE NEWSWIRE) -- F2G Ltd. today announced abstracts accepted for oral and poster presentation at IDWeek 2026, taking place October 21–24, 2026, at the Walter E. Washington Convention Center in...
Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
GlobeNewswire, Inc.
LAS VEGAS, NEVADA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotech developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, together with its...
CJ Biomaterials Secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery
GlobeNewswire, Inc.
PHACT™ CB0104A earned BPI Commercial and Home Compostable, TÜV AUSTRIA OK compost HOME & OK compost INDUSTRIAL Certifications New all-PHA compound is designed for cutlery, caps, enclosures, beauty packaging, and agriculture, and horticulture...
Ocugen to Participate in Upcoming Scientific Conferences
GlobeNewswire, Inc.
MALVERN, Pa., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that the Company will present on its...
WOW Expands to VIDAA Smart TVs in Austria
EIN Presswire
WOW, Sky's streaming service, launches on VIDAA Smart TVs in Austria, bringing premium series, movies and live sports to more viewers via the VIDAA App Store.
United Cerebral Palsy Announces 2026 Research Grant Awardees Advancing Innovation in Cerebral Palsy Care
EIN Presswire
Three projects will receive funding to advance clinical and translational research, improve care, and address gaps in diagnosis, treatment, and healthcare.
Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial
GlobeNewswire, Inc.
The Phase I clinical trial will evaluate a proprietary drug candidate formulated using Cyprumed’s oral tablet technology, marking the first Cyprumed technology program to enter human clinical development The milestone triggers a payment to...
JJP Biologics to Present Data Showing the Potential of Nebaprubart for Linear IgA Dermatosis (LAD) at Two Key Upcoming Scientific Conferences
GlobeNewswire, Inc.
Positive interim data from Phase Ib proof-of-concept trial will be presented at the IPPF Scientific Symposium on Pemphigus and Pemphigoid and at EADV Congress 2026 Data positions nebaprubart as a potential therapy across a broad range of...
One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by Virtual KOL Event
GlobeNewswire, Inc.
First clinical data for CPV-104 in patients, including interim safety, tolerability and pharmacokinetics, accepted as a late-breaking poster Expert panel to join One04 management in a virtual key opinion leader (KOL) event to discuss the data on...
WeAreDevelopers Launches its India Conference as the Country Bets on AI and Innovation
GlobeNewswire, Inc.
Bengaluru / Vienna, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Bengaluru / Vienna, October 5, 2026: WeAreDevelopers, the global platform behind the world's largest developer events, is coming to India.
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
GlobeNewswire, Inc.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe.
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
GlobeNewswire, Inc.
LAS VEGAS, NEVADA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), together with joint venture partner Austrianova, today announced that Prof. Walter H. Günzburg presented the companies’ encapsulated-cell...
Knowledge Networks and The American Bazaar Announce 'Powering the AI Decade' in Washington, DC
EIN Presswire
On Oct 15, leaders will convene in Vienna, VA, for "Powering the AI Decade" to discuss AI infrastructure, energy demands, and policy.
Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026
GlobeNewswire, Inc.
New non-human primate data show Coave's ligand-conjugated suprachoroidal vector, coAAV-SCS, achieved up to 120-fold higher retinal and RPE-choroid expression than existing AAV capsids Aflibercept expressed via coAAV-SCS reached clinically...
Sign up for:
Sci-Tech Press Austria
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.